← Back to Search

Beta Blocker

Carvedilol for High Blood Pressure

Phase 4
Waitlist Available
Led By Alan J Bank, M.D.
Research Sponsored by St. Paul Heart Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 5 months
Awards & highlights
Approved for 10 Other Conditions
Pivotal Trial
No Placebo-Only Group
All Individual Drugs Already Approved
Drug Has Already Been Approved

Summary

The purpose of this study is to compare the vascular effects of two commonly used blood pressure medications, carvedilol and metoprolol in hypertensive patients with type 2 diabetes.

Eligible Conditions
  • Diabetes
  • High Blood Pressure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 5 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Flow Mediated Dilation

Awards & Highlights

Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CarvedilolExperimental Treatment1 Intervention
Carvedilol, orally, 25 mg, twice daily for five months
Group II: MetoprololActive Control1 Intervention
Metoprolol, orally, 200 mg, twice daily for five months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Carvedilol
FDA approved

Find a Location

Who is running the clinical trial?

St. Paul Heart ClinicLead Sponsor
4 Previous Clinical Trials
211 Total Patients Enrolled
GlaxoSmithKlineIndustry Sponsor
4,805 Previous Clinical Trials
8,379,813 Total Patients Enrolled
Alan J Bank, M.D.Principal InvestigatorSt. Paul Heart Clinic
1 Previous Clinical Trials
36 Total Patients Enrolled
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top